RegulyzeBifidobacterium longum subsp. longum
Bifidobacterium longum subsp. longum is a probiotic strain permitted for use in nutraceuticals and health supplements under India's FSSAI framework. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | As specified / GMP | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Bifidobacterium longum subsp. longum
Bifidobacterium longum subsp. longum is tracked in the Regulyze Ingredient Intelligence database as a probiotic strain. The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Bifidobacterium longum subsp. longum permitted in nutraceuticals under FSSAI (India)?
Bifidobacterium longum subsp. longum is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Bifidobacterium longum subsp. longum?
No single numeric limit is listed in the source for Bifidobacterium longum subsp. longum; permitted use is at GMP or as specified. Confirm against the current regulation.
What product category does Bifidobacterium longum subsp. longum belong to?
Bifidobacterium longum subsp. longum is classified under: Probiotics.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.